Post-earnings recap
Reported
Tue, May 5, 2026
EPS actual
$2.90
EPS est.
$2.51
EPS surprise
+15.68%
1-day move
+9.62%
IQVIA's strong EPS performance exceeded analyst expectations, contributing to a significant stock increase of 9.62%. However, the lack of revenue data and management commentary leaves some uncertainty about the overall business outlook. Investors may be encouraged by the earnings beat but will likely be looking for more information in future reports.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.90 | $2.82 | +15.68% |
| Revenue | — | $4.1B | — |
No transcript is on record, and the analysis is based on numerical results only.
IQVIA Holdings Inc. operates in the health care sector, providing advanced analytics, technology solutions, and contract research services to the life sciences industry. With a market cap of $26 billion, the company plays a crucial role in helping pharmaceutical and biotech companies improve their research and development processes.
Last quarter
In Q4-2025, IQVIA reported an EPS of $3.42, exceeding expectations by 9.16%. However, the stock fell 10.65% the following day, indicating market concerns despite the earnings beat.
EPS beat streak
8Q
EPS beat rate
100%
Avg EPS surprise
+12.20%
Avg 1-day reaction
+3.07%
Analysts expect IQVIA to continue its trend of beating earnings estimates, with a consensus EPS of $2.82. However, the stock's recent volatility suggests that any surprises could lead to significant price movements.
Bull case
If IQVIA delivers strong earnings and revenue growth, it could reinforce investor confidence and lead to a positive stock reaction, especially given its history of beating estimates.
Bear case
Conversely, if the company fails to meet expectations or provides weak guidance, it could trigger a sharp decline in the stock price, reflecting ongoing market skepticism.
Key metrics to watch
EPS
$2.82Earnings per share is a key indicator of profitability and will show how well the company is managing costs and generating income.
Revenue
$4.1BRevenue figures will provide insight into the overall demand for IQVIA's services and how well it is capturing market opportunities.
The print will turn on these.
Q1
Will IQVIA's EPS exceed the consensus estimate of $2.82?
A beat on EPS could indicate strong operational performance and boost investor confidence, while a miss could raise concerns about the company's growth trajectory.
Q2
What guidance will management provide regarding future revenue growth?
Management's outlook on revenue growth will be critical for assessing the company's ability to navigate market challenges and capitalize on opportunities.
—
Est. EPS
$0.01
Est. Rev
$918M
Impl. Move
±9.1%
Why consensus could be wrong
The Street may underestimate IQVIA's ability to leverage new technology solutions that could drive higher revenue growth than anticipated.
Supporting evidence
The company has consistently beaten EPS estimates, indicating stronger operational performance than analysts expect.
The options market is pricing in a larger move than historical averages suggest, indicating potential for a surprise.
Recent insider activity shows mixed signals, which may imply uncertainty about future performance.
Key risk
If the company reports revenue growth significantly above $4.1 billion, it could challenge the current bearish sentiment.
Pre-commit to what would confirm each case.
The market is closely watching IQVIA's ability to deliver consistent earnings and revenue growth amidst a competitive landscape.
Bull confirmed if
An EPS of $2.90 or higher, along with revenue growth exceeding $4.1 billion, would confirm the bullish case.
Bear confirmed if
An EPS below $2.70 and revenue failing to meet expectations would validate the bearish outlook.
What the market is pricing for the move.
Implied Move
±9.65%
Historical Avg
±7.9%
The options market is pricing in a significant move, suggesting that traders anticipate volatility around the earnings report.
Options are pricing ±9.8% while IQV has averaged ±7.9% over the last 8 prints — setup is pricing rich.
ATM IV
0.7%
30d HV
37.5%
Smart-money positioning from the most recent 13F filings.
Institutional
103.51%
of float
Insider
1.09%
of float
Holders
1,558
institutions
Top Holders· as of Jun 2026
Blackrock Inc.
14,549,693 sh · $3.8B
8.84%
-3.2%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If IQVIA beats expectations, history suggests a potential stock increase of around +0.7%, confirming the company's strong performance.
In line / cautious
An in-line report may lead to muted reactions, with management's commentary driving the stock's direction based on future outlook.
Miss
If IQVIA misses estimates, the stock could decline significantly, as seen in past quarters with average drops following misses.
House and Senate STOCK Act disclosures over the trailing 6 months.
Trades
3
0 buys·3 sells
Members
1
House only
Est. Notional
$17,003.00–$80,000.00
disclosed dollar ranges
Most Active Members
3 trades
The lines on the call that would change the story.
Harris Associates L.P.
12,183,830 sh · $3.1B
7.40%
Flat
Vanguard Capital Management LLC
10,905,053 sh · $2.8B
6.63%
-1.1%
State Street Corporation
7,508,244 sh · $1.9B
4.56%
0.4%
Vanguard Portfolio Management LLC
7,501,993 sh · $1.9B
4.56%
-1.0%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.
Net selling
Recent Transactions
Traded Sep 14, 2026 · disclosed Sep 25, 2026
$15,001.00–$50,000.00
Traded Sep 8, 2026 · disclosed Sep 25, 2026
$1,001.00–$15,000.00
Traded Sep 3, 2026 · disclosed Sep 25, 2026
$1,001.00–$15,000.00
Filed 30–45+ days after the trade. Treat as positional context, not a leading indicator. Amounts are SEC-mandated dollar ranges, not exact values.